NRSN · NeuroSense Therapeutics Ltd.
Market Cap
$15.88M
Shares
37.77M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
No Proposed Sales
No Form 144 proposed-sale notices are available for this stock yet.
Key facts
CIK
1875091
CUSIP
M74240108
13F (30d)
12 filings
12 filers
Visit website
Investor relations